The research uses machine learning technology to look at structural features within the brain, including in regions not previously associated with Alzheimer’s. The advantage of the technique is… read more.
Inside the body, some seemingly harmless proteins have sinister potential. In the case of Alzheimer’s disease, the amyloid-beta (Aβ) protein, which is vital for brain growth, can become… read more.
Antidepressants are the first-choice treatment for severe depression. Antidepressant use is often supplemented by psychotherapy. Now a major ongoing international study has shown that adding psychotherapy treatment to… read more.
More than half of people diagnosed with one psychiatric disorder will be diagnosed with a second or third in their lifetime. About a third have four or more…. read more.
Effective clinical care for patients with psychosis means understanding the ‘lived experience’ of their delusions, say researchers at the Universities of Birmingham, York and Melbourne. By understanding the… read more.
Electroconvulsive therapy (ECT) led to a 47 per cent reduction suicide risk among depressed patients for a year after hospitalization. The findings were reported on April 26, 2022… read more.
Despite the ability of any Michigan pharmacy to dispense medication to combat opioid overdose without writing prescriptions, slightly more than half of pharmacies in the state offer the… read more.
A recent study by the Faculty of Sport and Health Sciences at the University of Jyväskylä and the Gerontology Research Center (Finland) investigated the paths from childhood socioemotional… read more.
In addition to memory problems and other cognitive symptoms, most people with Alzheimer’s disease also suffer from mental health issues. It has long been unclear whether these occur… read more.
Alcoholism, if left untreated, could have dangerous repercussions. Thus, it is no surprise that there are a range of drugs developed to treat this condition. Of these drugs,… read more.
A healthy lifestyle is not only linked with a longer life expectancy but also less frequency and length of Alzheimer’s dementia, researchers reported on April 13, 2022 in… read more.
AbbVie announced that it has submitted a supplemental New Drug Application (sNDA) for cariprazine (Vraylar) to the FDA for the adjunctive treatment of major depressive disorder (MDD) in… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
